Nepsis Inc’s United Therapeutics UTHR Stock Holding History

Nepsis Inc’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.4M	Buy	30,336 +3,063	+11%	+$1.58M	5.18%	5
2026 Q2	$14.8M	Sell	27,273 -14,921	-35%	-$8.4M	5.01%	9
2026 Q1	$25M	Sell	42,194 -1,566	-4%	-$780K	8.38%	1
2025 Q4	$21.3M	Sell	43,760 -656	-1%	-$305K	6.59%	1
2025 Q3	$18.6M	Sell	44,416 -3,356	-7%	-$1.13M	5.9%	1
2025 Q2	$13.7M	Sell	47,772 -10,802	-18%	-$3.23M	3.82%	15
2025 Q1	$18.1M	Buy	58,574 +3,653	+7%	+$1.25M	4.46%	9
2024 Q4	$19.4M	Buy	54,921 +3,113	+6%	+$1.14M	4.84%	10
2024 Q3	$18.6M	Buy	+51,808	New	+$17.5M	4.4%	10

Other funds holding UTHR

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

VFP

Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return

AAM

Augustine Asset Management Jacksonville, Florida $464M AUM 16.89% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return

NIM

Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Weil Company San Diego, California $580M AUM 14.7% 1-Year Est. Return

Nepsis Inc's UTHR Position: Q3 2026 in Review

Nepsis Inc increased its United Therapeutics (UTHR) stake by 11% in Q3 2026, buying an estimated $1.58M and bringing the position to 30,336 shares worth $16.4M. The position accounts for 5.18% of the portfolio, ranked #5.

Nepsis Inc first reported a position in UTHR in Q3 2024 and has held it in 9 quarters since. The position peaked at $25M in Q1 2026. 52 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Nepsis Inc held 30,336 shares of United Therapeutics worth $16.4M as of Q3 2026.
Nepsis Inc bought 3,063 United Therapeutics shares in Q3 2026, an estimated $1.58M.
United Therapeutics made up 5.18% of Nepsis Inc's portfolio in Q3 2026, its #5 holding.
Nepsis Inc first reported a position in United Therapeutics in Q3 2024 and has held it in 9 quarters since.
Nepsis Inc's United Therapeutics position peaked at $25M in Q1 2026.
52 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Nepsis Inc's 13F filing for Q3 2026, filed 13 Oct 2026.